Dcf Advisers, LLC Evotec Se Transaction History
Dcf Advisers, LLC
- $177 Million
- Q4 2024
A detailed history of Dcf Advisers, LLC transactions in Evotec Se stock. As of the latest transaction made, Dcf Advisers, LLC holds 229,871 shares of EVO stock, worth $1.02 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
229,871
Previous 217,055
5.9%
Holding current value
$1.02 Million
Previous $792,000
20.71%
% of portfolio
0.54%
Previous 0.33%
Shares
7 transactions
Others Institutions Holding EVO
# of Institutions
26Shares Held
2.91MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.3MShares$10.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY126KShares$559,0890.0% of portfolio
-
Black Rock Inc. New York, NY82.6KShares$366,7350.0% of portfolio
-
Goldman Sachs Group Inc New York, NY61.1KShares$271,3630.0% of portfolio
-
Lighthouse Investment Partners, LLC Palm Beach Gardens, FL39.8KShares$176,7250.01% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.57B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...